Navigation Links
Ranbaxy's Four HIV/AIDS Drugs In WHO Pre-Qualification List

India's biggest drug maker Ranbaxy Laboratories Limited today said the World Health Organistion has included four of its additional Anti Retro- Viral (ARV) products in its pre-qualification list. //

The products approved by WHO are Efavirenz 600mg tablets, Efavirenz 200mg capsules, Stavudine 30mg capsules, Stavudine 40mg capsules, the company said in a statement.

"This is a significant development. We strongly feel that Generic ARVs are essential in the struggle against HIV/AIDS and are committed to providing high quality, cost effective generics," Ranbaxy CEO and MD Malvinder Mohan Singh said.

With these inclusions, Ranbaxy now has a total of 12 ARVs on the WHO pre-qualification list. It also has three approvals from USFDA for ARVs, making it eligible for supplying to the US funded PEPFAR programme.

"Efavirenz is rapidly becoming a preferred drug in HIV treatment programme in developing countries. The other newly listed drug, Stavudine, is also being widely used as a first line of therapy against AIDS. Both products increase customer choice enabling patients to access therapy easily, at affordable prices," Singh added.

Ranbaxy has been providing ARVs at affordable prices to countries and patients afflicted by HIV/AIDS since 2001.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Optimum Timing for HIV/AIDS Prognosis
2. Estimates For Number Of HIV/AIDS Deaths In India Still Not Available
3. Testing For HIV/AIDS Compulsory For New Military Recruits
4. HIV/AIDS - May push Back the Tide of Progress in India
5. Indian Olympic Association And UNICEF To Collaborate On HIV/AIDS Awareness
6. Indian Minister wanted Media to Propaganda HIV/AIDS awareness
7. Relief for HIV/AIDS patients: ART therapy now available in India
8. Conditions Of The HIV/AIDS Patients In The Mizo Society
9. Liberia in safe hands with respect to HIV/AIDS
10. Men queue up for Circumcision In Swaziland To Prevent HIV/AIDS
11. HIV/AIDS Throws Family Relationships Out Of Gear In Uganda
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/5/2016)... ... May 05, 2016 , ... Textile Exchange is excited to announce ... stakeholder review. The stakeholder review is an important opportunity for interested parties to give ... value to the wool industry., The RWS is intended to be a global benchmark ...
(Date:5/5/2016)... Diego, CA (PRWEB) , ... May 05, 2016 , ... ... dashboard and dedicated Twitter feed to cover the latest news and commentary at the ... through 10th. This meeting of the American Society of Cataract and Refractive Surgery and ...
(Date:5/5/2016)... ... 2016 , ... TLC Laser Eye Centers announced today that it has acquired ... now be called “Gordon Schanzlin New Vision Institute, a TLC Laser Eye Center.” ... to ensure that patients continue to receive the highest quality of care. In addition, ...
(Date:5/5/2016)... ... May 05, 2016 , ... Spring Fertility , ... IVF and with egg freezing, today announced the grand opening of its first ... fertility care, Spring Fertility offers both fertility preservation (egg, sperm, embryo, and testicular ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... Seminars for Business Journalists , led by the Wharton School’s most prominent ... issues.  This one-day program at the Wharton School’s San Francisco campus will ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... Global NASH market report ... rise in obesity will fuel the demand for ... years. The NASH Market is growing at a ... of rising number of obesity among young population. ... with no FDA approved therapeutics. Antioxidants, anti-diabetic medications, ...
(Date:5/5/2016)... , May 5, 2016  Replikins Ltd. today reported initial promising results in animal ... Photo - http://photos.prnewswire.com/prnh/20160505/364345 ... ... ... of all Zika specimens recorded on Pubmed. The analysis identified the highest gene Replikin ...
(Date:5/5/2016)... , May 5, 2016  Endo International ... today announced that Brian Lortie , President, ... from his position upon the appointment of a ... led its U.S. Pharmaceuticals business with responsibility for ... and marketing, strategy and portfolio development, commercial operations, ...
Breaking Medicine Technology: